Insider Transactions in Q2 2021 at Nephros Inc (NEPH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2021
|
Wexford Capital LP |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
66,667
+1.85%
|
$133,334
$2.7 P/Share
|
|
May 24
2021
|
Daron Evans CEO of Specialty Renal Product |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,222
+10.82%
|
$4,444
$2.7 P/Share
|